Clinical Trials for Unresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Find clinical trials for unresectable or metastatic gastric/gastroesophageal junction adenocarcinoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma

NCT ID: NCT06932068

This clinical trial is investigating a new treatment option for adults with a specific type of advanced stomach cancer known as HER2-negative, low PD-L1 expressing gastric or gastroesophageal junct...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions